Check out Pro
Top CompaniesRecent TradesCluster BuysSectorsBlog
Join the Insiderviz Pro waitlist
Inozyme Pharma, Inc. (INZY)
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
1 Aug 2023
Hopfner Robert Lorne
Director
Inozyme Pharma, Inc.
(INZY)
2,923,110+39%
833,333
$4.80
$3,999,998.80
BUY
1 Aug 2023
Pivotal bioVenture Partners Fund I, L.P.
Director
Inozyme Pharma, Inc.
(INZY)
2,923,110+39%
833,333
$4.80
$3,999,998.80
BUY
29 Mar 2023
Hopfner Robert Lorne
Director
Inozyme Pharma, Inc.
(INZY)
3,213,586+12%
344,592
$4.54
$1,563,724.00
BUY
27 Mar 2023
Hopfner Robert Lorne
Director
Inozyme Pharma, Inc.
(INZY)
2,868,994+7%
207,840
$4.05
$841,063.30
BUY
15 Dec 2022
Bjarke Henric Bjorn
SVP, COO, Officer
Inozyme Pharma, Inc.
(INZY)
105,441+25%
21,500
$1.39
$29,885.00
BUY
19 Apr 2022
Subramanian Sanjay
SVP, CFO, Officer
Inozyme Pharma, Inc.
(INZY)
27,100+100%
27,100
$3.69
$99,999.00
BUY
19 Apr 2022
Bjarke Henric Bjorn
SVP, COO, Officer
Inozyme Pharma, Inc.
(INZY)
80,626+50%
27,100
$3.69
$99,999.00
BUY
19 Apr 2022
Pivotal bioVenture Partners Fund I, L.P.
Director
Inozyme Pharma, Inc.
(INZY)
2,661,154+67%
1,070,000
$3.69
$3,948,300.00
BUY
19 Apr 2022
Longitude Capital Partners III, LLC
10% Owner
Inozyme Pharma, Inc.
(INZY)
4,174,379+48%
1,355,000
$3.69
$4,999,950.00
BUY
19 Apr 2022
Bolte Axel
Chief Executive Officer, Director, Officer
Inozyme Pharma, Inc.
(INZY)
258,575+35%
67,750
$3.69
$249,997.50
BUY
19 Apr 2022
Hopfner Robert Lorne
Director
Inozyme Pharma, Inc.
(INZY)
2,661,154+67%
1,070,000
$3.69
$3,948,300.00
SELL
24 Jun 2021
Bolte Axel
Chief Executive Officer, Director, Officer
Inozyme Pharma, Inc.
(INZY)
190,825-25%
66,788
$0.00
$6.68
SELL
28 Jan 2021
Novo Holdings A/S
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,194,379-14%
375,000
$21.00
$7,875,000.00
BUY
28 Jul 2020
Sonsini Peter W.
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,437,689+11%
250,000
$16.00
$4,000,000.00
BUY
28 Jul 2020
Rock Springs Capital Management LP
10% Owner
Inozyme Pharma, Inc.
(INZY)
1,043,884+135%
600,000
$16.00
$9,600,000.00
BUY
28 Jul 2020
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,003,653+42%
600,000
$16.00
$9,600,000.00
BUY
28 Jul 2020
New Enterprise Associates 15, L.P.
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,437,689+11%
250,000
$16.00
$4,000,000.00
BUY
28 Jul 2020
Pivotal bioVenture Partners Fund I, L.P.
10% Owner
Inozyme Pharma, Inc.
(INZY)
1,591,154+13%
187,500
$16.00
$3,000,000.00
BUY
28 Jul 2020
SANDELL SCOTT D
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,437,689+11%
250,000
$16.00
$4,000,000.00
BUY
28 Jul 2020
Novo Holdings A/S
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,569,379+17%
375,000
$16.00
$6,000,000.00
BUY
28 Jul 2020
Sanofi
10% Owner
Inozyme Pharma, Inc.
(INZY)
520,125+18%
81,250
$16.00
$1,300,000.00
BUY
28 Jul 2020
MAKOWER JOSHUA
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,437,689+11%
250,000
$16.00
$4,000,000.00
BUY
28 Jul 2020
Makhzoumi Mohamad
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,437,689+11%
250,000
$16.00
$4,000,000.00
BUY
28 Jul 2020
Florence Anthony A. Jr.
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,437,689+11%
250,000
$16.00
$4,000,000.00
BUY
28 Jul 2020
BASKETT FOREST
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,437,689+11%
250,000
$16.00
$4,000,000.00
BUY
28 Jul 2020
Longitude Capital Partners III, LLC
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,819,379+28%
625,000
$16.00
$10,000,000.00
BUY
28 Jul 2020
Hopfner Robert Lorne
Director, 10% Owner
Inozyme Pharma, Inc.
(INZY)
1,591,154+13%
187,500
$16.00
$3,000,000.00
BUY
28 Jul 2020
Sofinnova Venture Partners X, L.P.
10% Owner
Inozyme Pharma, Inc.
(INZY)
2,028,308+27%
437,500
$16.00
$7,000,000.00
Home
Top CompaniesForm ScreenerSectors
DisclaimersPrivacyTerms of Service
ContactBlogNewsletter